- Book
- December 2019
- 200 Pages
- Book
- March 2022
- 896 Pages
- Book
- January 2022
- 336 Pages
- Book
- April 2021
- 288 Pages
- Book
- December 2020
- 432 Pages
- Book
- April 2018
- 432 Pages
- Book
- March 2018
- 1134 Pages
- Book
- January 2012
- 660 Pages
- Book
- July 2011
- 800 Pages
- Book
- October 2007
- 864 Pages
- Book
- May 2021
- 1488 Pages
Global
- Book
- May 2021
- 1488 Pages
Global
- Book
- August 2008
- 684 Pages

The oligonucleotide market is a subset of the biotechnology industry that focuses on the production and sale of oligonucleotides, which are short strands of nucleic acids used in a variety of applications. Oligonucleotides are used in research, diagnostics, and therapeutics, and are essential components of many biotechnological processes. They are used in a variety of applications, including gene expression analysis, gene cloning, and gene sequencing.
The oligonucleotide market is expected to grow in the coming years due to increasing demand for biotechnological products and services. The market is driven by advances in technology, such as the development of new sequencing techniques, and the increasing use of oligonucleotides in drug discovery and development.
Some of the major companies in the oligonucleotide market include Thermo Fisher Scientific, Illumina, Agilent Technologies, Merck KGaA, and Qiagen. These companies are involved in the production and sale of oligonucleotides, as well as the development of new technologies and products. Show Less Read more